ipamorelin clinical trials side effects Ipamorelin is a potent growth hormone-releasing peptide that has some Sermorelin vs CJC-1295 vs Ipamorelin:

Hwang, V

doi: 10.1152/ajpendo.00116.2005

It is theorized that the IGF-I produced in liver cells may be transported to various target tissues

[0312] Additionally chimeric constructs are provided that expand beyond targeted chemotherapy to immunotherapy by incorporating, for example, providing bispecific antibodies comprising an anti-ALPP/ALPPL2 antibody attached to a second antibody that is capable of recruiting and activating immune system components or attached to a moiety that is a checkpoint inhibitor {e.g., anti- CTLA4 {e.g., comprising an ipilimumab variable region), and/or antibodies directed against PD-L1 {e.g., comprising an nivolumab, or pembrolizumab variable region), and/or antibodies directed against PD-L2